GCL
ORGO icon

Glazer Capital LLC’s Organogenesis Holdings ORGO Stock Holding History

Glazer Capital LLC’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-100
Closed -$1K – 167
2019
Q1 		$1K Buy
+100
New +$2K ﹤0.01% 148
2018
Q4 		– Sell
-2,944,040
Closed -$29.8M – 162
2018
Q3 		$29.8M Sell
2,944,040
-54,904
-2% -$554K 3.14% 7
2018
Q2 		$30M Buy
2,998,944
+48,997
+2% +$491K 2.97% 9
2018
Q1 		$29.2M Sell
2,949,947
-10,119
-0.3% -$101K 3.08% 13
2017
Q4 		$29.4M Buy
2,960,066
+260,066
+10% +$2.58M 4.75% 7
2017
Q3 		$27M Buy
2,700,000
+1,494,440
+124% +$14.8M 2.58% 8
2017
Q2 		$11.9M Buy
1,205,560
+1,005,561
+503% +$9.89M 0.76% 27
2017
Q1 		$1.97M Buy
+199,999
New +$1.98M 0.22% 39

Other funds holding ORGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MC
Moors & Cabot Boston, Massachusetts $2.34B AUM 30.42% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Glazer Capital LLC's ORGO Position: Q2 2019 in Review

Glazer Capital LLC sold out of Organogenesis Holdings (ORGO) in Q2 2019, closing a stake of 100 shares — an estimated $1K sold.

Glazer Capital LLC first reported a position in ORGO in Q1 2017 and held it in 8 quarters. The position peaked at $30M in Q2 2018. 31 funds tracked by Wall St. Rank hold ORGO as of Q2 2019.

  • Glazer Capital LLC reported no remaining Organogenesis Holdings position as of Q2 2019 after selling out during the quarter.
  • Glazer Capital LLC sold 100 Organogenesis Holdings shares in Q2 2019, an estimated $1K.
  • Glazer Capital LLC first reported a position in Organogenesis Holdings in Q1 2017 and held it in 8 quarters.
  • Glazer Capital LLC's Organogenesis Holdings position peaked at $30M in Q2 2018.
  • 31 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2019.

Based on Glazer Capital LLC's 13F filing for Q2 2019, filed 15 Aug 2019.